Liisa Bayko Analyst Performance

Liisa Bayko is a stock analyst at Evercore ISI focused in the medical sector, covering 20 publicly traded companies. Over the past year, Liisa Bayko has issued 6 stock ratings, including buy and hold recommendations. While full access to Liisa Bayko's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Liisa Bayko's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Analyst Rating

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

40 Last 11 Years

Buy Recommendations

85.00% 34 Buy Ratings

Companies Covered

20 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	85.0%	34 ratings
Hold	10.0%	4 ratings
Sell	5.0%	2 ratings

Out of 40 total stock ratings issued by Liisa Bayko at Evercore ISI, the majority (85.0%) have been Buy recommendations, followed by 10.0% Hold and 5.0% Sell.

Best & Worst Calls

• Best Call

  0000.0%

  CRBP

  Mar 2016

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  TTPH

  Sep 2014

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	20 companies

Liisa Bayko, an analyst at Evercore ISI, currently covers 20 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 19 companies	95.0%
	Miscellaneous 1 company	5.0%

Liisa Bayko of Evercore ISI specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 9 companies	45.0%
PHARMACEUTICAL PREPARATIONS 5 companies	25.0%
MED - DRUGS 4 companies	20.0%
BIOTECHNOLOGY 1 company	5.0%
Miscellaneous 1 company	5.0%

Liisa Bayko's Ratings History at Evercore ISI

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
VRTX Vertex Pharmaceuticals	9/11/2025	Lower Price Target	$390.80	$475.00	Outperform	$0.00 00.00% ROI
ALNY Alnylam Pharmaceuticals	9/11/2025	Boost Price Target	$468.51	$515.05	Outperform	$0.00 00.00% ROI
SVRA Savara	5/28/2025	Lower Price Target	$2.09	$2.00	In-Line	$0.00 00.00% ROI
CRSP CRISPR Therapeutics	2/14/2025	Upgrade	$43.49	$99.00	Outperform	$0.00 00.00% ROI
TVTX Travere Therapeutics	2/12/2025	Boost Price Target	$24.01	$45.00	Outperform	$0.00 00.00% ROI
BCRX BioCryst Pharmaceuticals	1/13/2025	Boost Price Target	$7.63	$12.00	Outperform	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.